Anti-aging, which encompasses slow aging and reverse aging that youth cells, has become a health trend. While attention is ...

Popular weight loss drugs such as Wegovy and Zepbound have shown incredible success in clinical trials. But in the real world ...

When researchers analyzed weight loss results from patients who took GLP-1 drugs and those who'd undergone bariatric surgery, one method led to much more weight loss.

Weight-loss medications known as glucagon-like peptide-1 (GLP-1) agonists, which have gained popularity for treating type 2 diabetes and obesity, have been shown to have the surprising secondary ...

In conclusion, while weight loss medications such as semaglutide and tirzepatide offer promising short-term results, they often fail to deliver sustainable outcomes once treatment ends.

Pennsylvania Governor Josh Shapiro's office has said it is looking to change eligibility for weight loss drugs as part of its 2025-26 budget plans.

A study from Mass General Brigham and Harvard Medical School raises questions about a new class of weight loss drugs — and ...

Many focus on what weight-loss drugs take away: pounds. But they also offer patients something new: a sense of agency.

An important implication, for instance, is that if a person doesn’t respond well or experiences intolerable side effects with one weight loss medication, they have another option to try.

Experts say that semaglutide and tirzepatide can help patients with heart failure lose weight, but limited NHS access is ...

So is it enough for a doctor to tell a chronically obese person to lose weight and leave it at that? Wyatt and Bray both point out that we routinely use medication for other conditions that can be ...